Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.

Ramirez-Busby SM, Valafar F.

Antimicrob Agents Chemother. 2015 Sep;59(9):5267-77. doi: 10.1128/AAC.00204-15. Epub 2015 Jun 15.

2.

'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.

Zhang Y, Chiu Chang K, Leung CC, Wai Yew W, Gicquel B, Fallows D, Kaplan G, Chaisson RE, Zhang W.

Emerg Microbes Infect. 2012 Jul;1(7):e5. doi: 10.1038/emi.2012.18. Epub 2012 Jul 25. Review.

3.

Demonstrating a multi-drug resistant Mycobacterium tuberculosis amplification microarray.

Linger Y, Kukhtin A, Golova J, Perov A, Qu P, Knickerbocker C, Cooney CG, Chandler DP.

J Vis Exp. 2014 Apr 25;(86). doi: 10.3791/51256.

4.

Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.

Chang KC, Yew WW, Zhang Y.

Antimicrob Agents Chemother. 2011 Oct;55(10):4499-505. doi: 10.1128/AAC.00630-11. Epub 2011 Jul 18. Review.

5.

Microarray hybridization for assessment of the genetic stability of chimeric West Nile/dengue 4 virus.

Laassri M, Bidzhieva B, Speicher J, Pletnev AG, Chumakov K.

J Med Virol. 2011 May;83(5):910-20. doi: 10.1002/jmv.22033. Epub 2011 Feb 25.

6.

Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.

Muthaiah M, Jagadeesan S, Ayalusamy N, Sreenivasan M, Prabhu SS, Muthuraj U, Senthilkumar K, Veerappan S.

Int J Mol Sci. 2010 Jul 7;11(7):2670-80. doi: 10.3390/ijms11072670.

7.

Basic concepts of microarrays and potential applications in clinical microbiology.

Miller MB, Tang YW.

Clin Microbiol Rev. 2009 Oct;22(4):611-33. doi: 10.1128/CMR.00019-09. Review.

8.

Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus.

Garritano S, Gemignani F, Voegele C, Nguyen-Dumont T, Le Calvez-Kelm F, De Silva D, Lesueur F, Landi S, Tavtigian SV.

BMC Genet. 2009 Feb 17;10:5. doi: 10.1186/1471-2156-10-5.

9.

Genotyping of measles virus in clinical specimens on the basis of oligonucleotide microarray hybridization patterns.

Neverov AA, Riddell MA, Moss WJ, Volokhov DV, Rota PA, Lowe LE, Chibo D, Smit SB, Griffin DE, Chumakov KM, Chizhikov VE.

J Clin Microbiol. 2006 Oct;44(10):3752-9.

10.

Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates.

Park H, Song EJ, Song ES, Lee EY, Kim CM, Jeong SH, Shin JH, Jeong J, Kim S, Park YK, Bai GH, Chang CL.

J Clin Microbiol. 2006 May;44(5):1619-24.

11.

Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region.

McCammon MT, Gillette JS, Thomas DP, Ramaswamy SV, Rosas II, Graviss EA, Vijg J, Quitugua TN.

Antimicrob Agents Chemother. 2005 Jun;49(6):2210-7.

12.

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.

Rodrigues Vde F, Telles MA, Ribeiro MO, Cafrune PI, Rossetti ML, Zaha A.

Antimicrob Agents Chemother. 2005 Jan;49(1):444-6. Erratum in: Antimicrob Agents Chemother. 2006 Nov;50(11):3970.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk